THE MEDICINES COMPANY
The Medicines Company is focused on advancing the treatment of critical care patients through the delivery of innovative, cost-effective medicines to the worldwide hospital marketplace. The Company markets Angiomax(R) (bivalirudin) in the United States and other countries for use in patients undergoing coronary angioplasty, and Cleviprex(R) (clevidipine butyrate) injectable emulsion in the United States for the reduction of blood pressure when oral therapy is not feasible or not desirable. The Company also has two products in late stage development: cangrelor, an investigational antiplatelet agent, and oritavancin, a semi-synthetic lipoglycopeptide antibiotic. The Company's pipeline also includes a serine protease inhibitor, CU2010, in early-stage development.
THE MEDICINES COMPANY
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1996-01-01
Address:
Parsippany, New Jersey, United States
Country:
United States
Website Url:
http://www.themedicinescompany.com
Total Employee:
1001+
Status:
Closed
Contact:
(973) 290-6000
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Global Site Tag IPv6 CDN JS Cloudflare Hosting IIS IIS 7 Cookie Consent By Osano Silktide Cookie Consent ASP.NET 2.0 Akamai DNS
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2015-02-04 | Annovation BioPharma | Annovation BioPharma acquired by The Medicines Company | N/A |
| 2014-04-23 | Tenaxis Medical | Tenaxis Medical acquired by The Medicines Company | N/A |
| 2013-12-04 | Rempex Pharmaceuticals | Rempex Pharmaceuticals acquired by The Medicines Company | 474 M USD |
| 2013-08-05 | ProFibrix | ProFibrix acquired by The Medicines Company | 240 M USD |
| 2012-12-12 | Incline Therapeutics | Incline Therapeutics acquired by The Medicines Company | N/A |
| 2009-12-22 | ApoA-I Milano | ApoA-I Milano acquired by The Medicines Company | N/A |
| 2009-01-13 | Targanta Therapeutics | Targanta Therapeutics acquired by The Medicines Company | 42 M USD |
| 2008-08-05 | Curacyte Discovery GmbH | Curacyte Discovery GmbH acquired by The Medicines Company | N/A |
Investors List
Hanseatic Asset Management
Hanseatic Asset Management investment in Venture Round - The Medicines Company
Biotech Growth
Biotech Growth investment in Venture Round - The Medicines Company
Credit Suisse
Credit Suisse investment in Venture Round - The Medicines Company
Warburg Pincus
Warburg Pincus investment in Venture Round - The Medicines Company
Alta Partners
Alta Partners investment in Venture Round - The Medicines Company
GeneChem
GeneChem investment in Venture Round - The Medicines Company
Moore Capital
Moore Capital investment in Venture Round - The Medicines Company
BancAmerica Robertson Stephens
BancAmerica Robertson Stephens investment in Venture Round - The Medicines Company
Morgan Stanley Venture Partners
Morgan Stanley Venture Partners investment in Venture Round - The Medicines Company
Official Site Inspections
http://www.themedicinescompany.com
- Host name: 104.18.3.191
- IP address: 104.18.3.191
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
